UNSPSC 51433301: Cromakalim or levcromakalim

This classification denotes an antihypertensive agent with the molecular formula C16H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0G4X367WA3, chemically known as 2h-1-benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-, trans-(+-)- but generally known as cromakalim, which bears US NIH Compound Identifier 71191. European Medicines Agency schedules Cromakalim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06822MIG.

UNSPSC 51433301 Cromakalim or levcromakalim is a Commodity code that captures pharmaceutical procurement by state and local emergency-response agencies, specifically advanced life support medications used in pre-hospital care. State and local governments use this code to source critical injectable medications—including epinephrine, adenosine, diltiazem, and labetalol—that paramedics and fire-rescue personnel administer in the field. The solicitations under this code reflect purchases by municipal fire and emergency medical services departments, which procure these pharmaceuticals in relatively small volumes measured in hundreds to low thousands of units per medication line item. Vendors supplying under this code must meet stringent pharmaceutical quality standards, maintain shelf-life guarantees (typically nine months or more from delivery), warrant defect-free materials for extended periods, and comply with OSHA Hazard Communication Standards and FDA/state pharmacy regulations.

The City of Tampa's Purchasing Department posted an IFB for Advanced Life Support Medications (Solicitation 26P00188) on April 24, 2026, with a response date of April 8, 2026, sourcing four medication types totaling approximately 3,550 units for Tampa Fire Rescue in Hillsborough County, Florida, under an estimated contract value of $40,000.00. The solicitation offered a 5 percent Small Local Business Enterprise sheltered-market bid discount (capped at $10,000) and included a one-year base contract term with two optional one-year renewals plus three unilateral 30-day extension periods. The source contains a single recent opportunity under this code; geographic and issuing-body concentration cannot be characterized from a single solicitation.